Co-processed excipients

As commonly known, the product development stage is quite complex, requires intensive knowledge, and is time-consuming. The selection of the...

There is strong clinical need for pediatric formulations from healthcare professionals and caregivers since the number of available pediatric formulation...

The purpose of the study was to develop a novel, directly compressible, co-processed excipient capable of providing a controlled-release drug...

The selection of appropriate functional co-processed excipient (CPE) is a crucial stage in orodispersible minitablets (ODMTs) development. This paper aimed...

“Continuous Manufacturing (CM)” is a manufacturing method in which raw or blended materials are continuously charged to the processing line,...

The U.S. Food and Drug Administration (FDA) emphasizes drug product development by Quality by Design (QbD). Critical material attributes (CMAs)...

There is a high unmet medical need for child-appropriate oral dosage forms. The acceptability of a novel placebo orally dispersible...

Tablets constitute about 80–90% of dosage forms commonly prescribed by medical practitioners for therapeutic management of disease conditions. It is...

Palatability and patient acceptability are critical attributes of dispersible tablet formulation. Co-processed excipients could provide improved organoleptic profile due to...

Tableting by direct compression (DC) is one of the simplest and most cost-effective drug manufacturing approaches. However, most active pharmaceutical...